Alexandros Papachristofilou
Papers
1
Total Citations
152
H-Index
1
About
Alexandros Papachristofilou is a leading radiation oncologist whose research centers on stereotactic body radiotherapy (SBRT) for oligometastatic disease, with a particular focus on liver and lung malignancies. He is a key figure in the German Society for Radiation Oncology (DEGRO) SBRT database initiative, which pools multicenter data to establish evidence-based patterns of care. His most cited work, a 2018 analysis of 474 patients with 623 liver oligometastases treated with SBRT (152 citations), provides critical insights into factors influencing local control and overall survival, helping to define SBRT’s role in managing limited metastatic spread. This research has shaped clinical guidelines by demonstrating high rates of treated metastasis control with low toxicity. Papachristofilou’s contributions extend to investigating SBRT for central and ultra-central lung tumors, where he has addressed safety and efficacy in challenging anatomical locations. His work is widely cited by radiation oncologists and surgical oncologists, reflecting its impact on refining non-invasive ablative therapies. Through the DEGRO initiative, he continues to advance personalized, evidence-based radiotherapy for patients with oligometastatic cancer.
Research Focus
Key Achievements
Top Papers
- 1